Residual stromal bed thickness correlates with regression of myopia after LASIK
Authors Ogasawara K, Onodera T
Received 5 July 2016
Accepted for publication 29 August 2016
Published 12 October 2016 Volume 2016:10 Pages 1977—1981
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Amy Norman
Peer reviewer comments 5
Editor who approved publication: Dr Scott Fraser
Kosuke Ogasawara, Tsuyoshi Onodera
Ogasawara Eye Clinic, Morioka, Japan
Purpose: The purpose of this study was to evaluate the correlation between residual stromal bed thickness (hereinafter bed thickness) and regression of myopia after LASIK, taking into consideration the long-term outcomes.
Subjects and methods: A total of 177 patients (309 eyes) and 41 patients (70 eyes) were retrospectively reviewed at 5 and 10 years after surgery, respectively. These patients were also continuously examined throughout the study. All patients underwent laser in situ keratomileusis (LASIK) for myopia in our clinic and scored at least 1.0 (0 logMAR) uncorrected distance visual acuity (UCVA) 1 month after surgery. Bonferroni–Dunn method and Student’s t-test were used for statistical analyses.
Results: Cases with a refractive value (spherical equivalent) of less than -6.0 D (Group A) were compared to those with -6.1 D or higher (Group B). There was a statistically significant decrease in Group B UCVA of 0.04 logMAR and 0.12 logMAR at 5 and 10 years after surgery, respectively. With regard to the relationship between regression of myopia and bed thickness in the long-term, there was a significantly higher frequency of regression of myopia in cases with less than 350 µm bed thickness compared to those with 350 µm and more, in a surgical volume of more than -6.1 D (Group B).
Conclusion: The present study indicates that bed thickness correlates with regression of myopia after LASIK and enough bed thickness is important to maintain good UCVA in the long-term.
Keywords: LASIK, regression, residual stromal bed thickness
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]